The authors showed that broadening the number of neoantigen-reactive CD8+ T cell populations between pre-treatment to three weeks post-treatment distinguished patients with controlled disease compared to patients with progressive disease in metastatic urothelial carcinoma treated with PD-L1-blockade.
[Nature Communications]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
173991
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/